Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort

INTRODUCTION: Individuals with screen-detected diabetes are likely to receive intensified pharmacotherapy to improve glycaemic control and general cardiometabolic health. Individuals are often asymptomatic, and little is known about the degree to which polypharmacy is present both before, and after...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, James A, Simmons, Rebecca K, Boothby, Clare E, Davies, Melanie J, Webb, David, Khunti, Kamlesh, Long, Gráinne H, Griffin, Simon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593027/
https://www.ncbi.nlm.nih.gov/pubmed/26448867
http://dx.doi.org/10.1136/bmjdrc-2014-000075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593027/
https://www.ncbi.nlm.nih.gov/pubmed/26448867
http://dx.doi.org/10.1136/bmjdrc-2014-000075

Ejemplares similares